title: Thalidomide-induced severe facial erythema in a patient with hepatocellular carcinoma.
authors.forename: C-C
authors.initials: CC
authors.lastname: Chiou
authors.forename: I-H
authors.initials: IH
authors.lastname: Shih
authors.forename: Y-C
authors.initials: YC
authors.lastname: Chang
authors.forename: J C
authors.initials: JC
authors.lastname: Lee
authors.forename: S-C
authors.initials: SC
authors.lastname: Kuo
authors.forename: H-S
authors.initials: HS
authors.lastname: Hong
authors.forename: C-H
authors.initials: CH
authors.lastname: Yang
mesh_terms: D000368:Aged; D006528:Carcinoma, Hepatocellular / Q000188:drug therapy*; D004890:Erythema / Q000139:chemically induced*; D006801:Humans; D007166:Immunosuppressive Agents / Q000009:adverse effects*; D008113:Liver Neoplasms / Q000188:drug therapy*; D008297:Male; D013792:Thalidomide / Q000009:adverse effects*
chemical_list: D007166:Immunosuppressive Agents; D013792:Thalidomide